Literature DB >> 19122025

Levels of evidence: Taking Neurology to the next level.

Robert A Gross, Karen C Johnston.   

Abstract

Mesh：

Year:  2009        PMID： 19122025     DOI： 10.1212/01.wnl.0000342200.58823.6a

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  22 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Prophylactic anticonvulsants in patients with primary glioblastoma.

Authors:  Arvin R Wali; Robert C Rennert; Sonya G Wang; Clark C Chen
Journal:  J Neurooncol       Date:  2017-07-28       Impact factor: 4.130

3.  Retention of Alzheimer Disease Research Participants.

Authors:  Joshua D Grill; Jimmy Kwon; Merilee A Teylan; Aimee Pierce; Eric D Vidoni; Jeffrey M Burns; Allison Lindauer; Joseph Quinn; Jeff Kaye; Daniel L Gillen; Bin Nan
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Oct-Dec       Impact factor: 2.703

Review 4.  Exercise Training for Persons with Alzheimer's Disease and Caregivers: A Review of Dyadic Exercise Interventions.

Authors:  Guillaume Lamotte; Raj C Shah; Orly Lazarov; Daniel M Corcos
Journal:  J Mot Behav       Date:  2016-11-21       Impact factor: 1.328

5.  Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout.

Authors:  Shana D Stites; R Scott Turner; Jeanine Gill; Anna Gurian; Jason Karlawish; Joshua D Grill
Journal:  Clin Trials       Date:  2021-01-10       Impact factor: 2.486

6.  Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures.

Authors:  W C LaFrance; G I Keitner; G D Papandonatos; A S Blum; J T Machan; C E Ryan; I W Miller
Journal:  Neurology       Date:  2010-08-25       Impact factor: 9.910

Review 7.  Endovascular therapy for acute ischemic stroke: a systematic review and meta-analysis.

Authors:  Balwinder Singh; Ajay K Parsaik; Larry J Prokop; Manoj K Mittal
Journal:  Mayo Clin Proc       Date:  2013-10       Impact factor: 7.616

Review 8.  Role of cannabinoids in multiple sclerosis.

Authors:  John P Zajicek; Vicentiu I Apostu
Journal:  CNS Drugs       Date:  2011-03       Impact factor: 5.749

Review 9.  Ketamine administration in depressive disorders: a systematic review and meta-analysis.

Authors:  Guillaume Fond; Anderson Loundou; Corentin Rabu; Alexandra Macgregor; Christophe Lançon; Marie Brittner; Jean-Arthur Micoulaud-Franchi; Raphaelle Richieri; Philippe Courtet; Mocrane Abbar; Matthieu Roger; Marion Leboyer; Laurent Boyer
Journal:  Psychopharmacology (Berl)       Date:  2014-07-20       Impact factor: 4.530

10.  Deep Brain Stimulation for Multiple Sclerosis Tremor: A Meta-Analysis.

Authors:  Nicholas J Brandmeir; Ann Murray; Cletus Cheyuo; Christopher Ferari; Ali R Rezai
Journal:  Neuromodulation       Date:  2019-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.